Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines.

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines.

Item
http://www.wikidata.org/entity/Q34708423
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical CancerCharacterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging AlphavirusesToll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγThe chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.Using macrophage activation to augment immunotherapy of established tumours.New Approaches to Immunotherapy for HPV Associated Cancers.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune PathwaysImmunologic treatments for precancerous lesions and uterine cervical cancer.Induction of tumor regression by intratumoral STING agonists combined with anti-programmed death-L1 blocking antibody in a preclinical squamous cell carcinoma model.Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Emerging human papillomavirus vaccines
P2860

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines.

Item
http://www.wikidata.org/entity/Q34708423
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@ast
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@en
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@nl
type
label
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@ast
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@en
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@nl
prefLabel
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@ast
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@en
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Vascular disrupting agent DMXA ...... therapeutic HPV DNA vaccines.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P698
P932